Moriya Tsuji - Publications

Affiliations: 
Department of Medical and Molecular Parasitology New York University 

131 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Tsuji M, Nair MS, Masuda K, Castagna C, Chong Z, Darling TL, Seehra K, Hwang Y, Ribeiro ÁL, Ferreira GM, Corredor L, Coelho-Dos-Reis JGA, Tsuji Y, Mori M, Boon ACM, et al. An immunostimulatory glycolipid that blocks SARS-CoV-2, RSV, and influenza infections in vivo. Nature Communications. 14: 3959. PMID 37402814 DOI: 10.1038/s41467-023-39738-1  0.322
2022 Watson FN, Duncombe CJ, Kalata AC, Conrad E, Chakravarty S, Sim BKL, Hoffman SL, Tsuji M, Shears MJ, Murphy SC. Sex-Specific Differences in Cytokine Induction by the Glycolipid Adjuvant 7DW8-5 in Mice. Biomolecules. 13. PMID 36671393 DOI: 10.3390/biom13010008  0.34
2022 Phares TW, Huang J, Kotraiah V, Hauser MJ, Domi A, Oruganti S, Browne CD, Buontempo P, Mansour M, Pannucci J, Tsuji M, Gutierrez GM. Viral delivery of a peptide-based immunomodulator enhances T cell priming during vaccination. Frontiers in Pharmacology. 13: 1029636. PMID 36582528 DOI: 10.3389/fphar.2022.1029636  0.42
2022 Moreira ML, Borges-Fernandes LO, Pascoal-Xavier MA, Ribeiro ÁL, Pereira VHS, Pediongco T, Araújo MSDS, Teixeira-Carvalho A, de Carvalho AL, Mourão MVA, Campos FA, Borges M, Carneiro M, Chen Z, Saunders E, ... ... Tsuji M, et al. The role of mucosal-associated invariant T cells in visceral leishmaniasis. Frontiers in Immunology. 13: 926446. PMID 36189274 DOI: 10.3389/fimmu.2022.926446  0.36
2022 Xu Y, Zhou Z, Brooks B, Ferguson T, Obliosca J, Huang J, Kaneko I, Iwanaga S, Yuda M, Tsuji Y, Zhang H, Luo CC, Jiang X, Kong XP, Tsuji M, et al. Layer-by-Layer Delivery of Multiple Antigens Using Trimethyl Chitosan Nanoparticles as a Malaria Vaccine Candidate. Frontiers in Immunology. 13: 900080. PMID 36059505 DOI: 10.3389/fimmu.2022.900080  0.332
2022 Teixeira AR, Pérez-Cabezas B, Costa DM, Sá M, Golba S, Sefiane-Djemaoune H, Ribeiro J, Kaneko I, Iwanaga S, Yuda M, Tsuji M, Boscardin SB, Amino R, Cordeiro-da-Silva A, Tavares J. Immunization with CSP and a RIG-I Agonist is Effective in Inducing a Functional and Protective Humoral Response Against . Frontiers in Immunology. 13: 868305. PMID 35669785 DOI: 10.3389/fimmu.2022.868305  0.382
2021 He X, Zhou S, Dolan M, Shi Y, Wang J, Quinn B, Jahagirdar D, Huang WC, Tsuji M, Pili R, Ito F, Ortega J, Abrams SI, Ebos JML, Lovell JF. Immunization with short peptide particles reveals a functional CD8 T-cell neoepitope in a murine renal carcinoma model. Journal For Immunotherapy of Cancer. 9. PMID 34862254 DOI: 10.1136/jitc-2021-003101  0.362
2021 Ribeiro ÁL, Araújo FP, Martins JP, Lourenço AA, Huang J, Pereira FV, Andrade LAF, Paim AAO, da Fonseca FG, Stancioli EFB, Martins-Filho OA, Peruhype-Magalhães V, Tsuji M, Coelho-Dos-Reis JG. A chimeric HLA-A2:β2M:Ig fusion protein for the study of virus-specific CD8 T-cells. Journal of Immunological Methods. 112997. PMID 33600818 DOI: 10.1016/j.jim.2021.112997  0.431
2020 Huang J, Zhou J, Ghinnagow R, Seki T, Iketani S, Soulard D, Paczkowski P, Tsuji Y, MacKay S, Cruz LJ, Trottein F, Tsuji M. Targeted Co-delivery of Tumor Antigen and α-Galactosylceramide to CD141 Dendritic Cells Induces a Potent Tumor Antigen-Specific Human CD8 T Cell Response in Human Immune System Mice. Frontiers in Immunology. 11: 2043. PMID 32973811 DOI: 10.3389/fimmu.2020.02043  0.423
2020 Phares TW, Kotraiah V, Karunarathne DS, Huang J, Browne CD, Buontempo P, Mansour M, Noe AR, Wykes MN, Pannucci J, Tsuji M, Gutierrez GM. A Peptide-Based PD1 Antagonist Enhances T-Cell Priming and Efficacy of a Prophylactic Malaria Vaccine and Promotes Survival in a Lethal Malaria Model. Frontiers in Immunology. 11: 1377. PMID 32733457 DOI: 10.3389/Fimmu.2020.01377  0.493
2020 Kotraiah V, Phares TW, Browne CD, Pannucci J, Mansour M, Noe AR, Tucker KD, Christen JM, Reed C, MacKay A, Weir GM, Rajagopalan R, Stanford MM, Chung CS, Ayala A, ... ... Tsuji M, et al. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics. Frontiers in Immunology. 11: 264. PMID 32210956 DOI: 10.3389/Fimmu.2020.00264  0.421
2019 Trauner D, Hartrampf N, Seki T, Baumann A, Watson P, Hoffmann-Röder A, Tsuji M, Veprek N, Hetzler B. Optical Control of Cytokine Production Using Photoswitchable Galactosylceramides. Chemistry (Weinheim An Der Bergstrasse, Germany). PMID 31788876 DOI: 10.1002/Chem.201905279  0.304
2019 Kalpana K, Yap S, Iyengar R, Tsuji M, Kawamura A. Cell-line based assay for the toxicity/benefit analysis of lipopolysaccharides in plants. Chemical Biology & Drug Design. PMID 31733132 DOI: 10.1111/Cbdd.13646  0.342
2019 Coelho-Dos-Reis JGA, Funakoshi R, Huang J, Pereira FV, Iketani S, Tsuji M. Functional Human CD141+ Dendritic Cells in Human Immune System Mice. The Journal of Infectious Diseases. PMID 31647546 DOI: 10.1093/Infdis/Jiz432  0.432
2019 Feng H, Nakajima N, Wu L, Yamashita M, Lopes TJS, Tsuji M, Hasegawa H, Watanabe T, Kawaoka Y. A Glycolipid Adjuvant, 7DW8-5, Enhances the Protective Immune Response to the Current Split Influenza Vaccine in Mice. Frontiers in Microbiology. 10: 2157. PMID 31620111 DOI: 10.3389/Fmicb.2019.02157  0.35
2019 Tsuji M. Review for "Accelerated thymopoiesis and improved T cell responses in HLA‐A2/‐DR2 transgenic BRGS‐based human immune system mice" European Journal of Immunology. DOI: 10.1002/Eji.201848001/V2/Review2  0.491
2018 Coelho-Dos-Reis JG, Li X, Tsuji M. Development of a novel mechanism-based glycolipid adjuvant for vaccination. F1000research. 7. PMID 29904582 DOI: 10.12688/F1000Research.13794.1  0.499
2018 Evering TH, Tsuji M. Human Immune System Mice for the Study of Human Immunodeficiency Virus-Type 1 Infection of the Central Nervous System. Frontiers in Immunology. 9: 649. PMID 29670623 DOI: 10.3389/Fimmu.2018.00649  0.345
2018 Waltari E, Jia M, Jiang CS, Lu H, Huang J, Fernandez C, Finzi A, Kaufmann DE, Markowitz M, Tsuji M, Wu X. 5' Rapid Amplification of cDNA Ends and Illumina MiSeq Reveals B Cell Receptor Features in Healthy Adults, Adults With Chronic HIV-1 Infection, Cord Blood, and Humanized Mice. Frontiers in Immunology. 9: 628. PMID 29632541 DOI: 10.3389/Fimmu.2018.00628  0.332
2018 McKenna KC, Tsuji M. Comment on "γδ T Cells Are Required for the Induction of Sterile Immunity during Irradiated Sporozoite Vaccinations". Journal of Immunology (Baltimore, Md. : 1950). 200: 1533. PMID 29463687 DOI: 10.4049/Jimmunol.1701743  0.463
2018 Fernandez-Arias C, Arias CF, Zhang M, Herrero MA, Acosta FJ, Tsuji M. Modeling the effect of boost timing in murine irradiated sporozoite prime-boost vaccines. Plos One. 13: e0190940. PMID 29329308 DOI: 10.1371/Journal.Pone.0190940  0.437
2017 Zhang M, Mandraju R, Rai U, Shiratsuchi T, Tsuji M. Monoclonal Antibodies against Plasmodium falciparum Circumsporozoite Protein Antibodies. 6: 11. PMID 31548526 DOI: 10.3390/Antib6030011  0.368
2017 Zhang M, Gallego-Delgado J, Fernandez-Arias C, Waters NC, Rodriguez A, Tsuji M, Wek RC, Nussenzweig V, Sullivan WJ. Inhibiting the Plasmodium eIF2α Kinase PK4 Prevents Artemisinin-Induced Latency. Cell Host & Microbe. 22: 766-776.e4. PMID 29241041 DOI: 10.1016/J.Chom.2017.11.005  0.321
2017 Shiratsuchi T, Rai U, Kaneko I, Zhang M, Iwanaga S, Yuda M, Tsuji M. A potent malaria vaccine based on adenovirus with dual modifications at Hexon and pVII. Vaccine. PMID 29089194 DOI: 10.1016/J.Vaccine.2017.10.066  0.545
2017 Nayak DK, Zhou F, Xu M, Huang J, Tsuji M, Yu J, Hachem R, Gelman AE, Bremner RM, Smith MA, Mohanakumar T. Zbtb7a induction in alveolar macrophages is implicated in anti-HLA-mediated lung allograft rejection. Science Translational Medicine. 9. PMID 28701473 DOI: 10.1126/Scitranslmed.Aal1243  0.313
2017 Nogueira RT, Sahi V, Huang J, Tsuji M. Human IgG repertoire of malaria antigen-immunized human immune system (HIS) mice. Immunology Letters. PMID 28610800 DOI: 10.1016/J.Imlet.2017.06.001  0.494
2017 Moreira ML, Tsuji M, Corbett AJ, Araújo MSS, Teixeira-Carvalho A, Martins-Filho OA, Peruhype-Magalhães V, Coelho-Dos-Reis JG. MAIT-cells: A tailor-made mate in the ancient battle against infectious diseases? Immunology Letters. 187: 53-60. PMID 28526582 DOI: 10.1016/J.Imlet.2017.05.007  0.44
2017 Li X, Huang J, Kawamura A, Funakoshi R, Porcelli SA, Tsuji M. Co-localization of a CD1d-binding glycolipid with an adenovirus-based malaria vaccine for a potent adjuvant effect. Vaccine. PMID 28483194 DOI: 10.1016/J.Vaccine.2017.04.077  0.442
2017 Zhou J, Kaiser A, Ng C, Karcher R, McConnell T, Paczkowski P, Fernandez C, Zhang M, Mackay S, Tsuji M. CD8+ T-cell mediated anti-malaria protection induced by malaria vaccines; assessment of hepatic CD8+ T cells by SCBC assay. Human Vaccines & Immunotherapeutics. 0. PMID 28362549 DOI: 10.1080/21645515.2017.1304333  0.505
2017 Guillaume J, Seki T, Decruy T, Venken K, Elewaut D, Tsuji M, Van Calenbergh S. Synthesis of C6''-modified α-C-GalCer analogues as mouse and human iNKT cell agonists. Organic & Biomolecular Chemistry. PMID 28221388 DOI: 10.1039/C7Ob00081B  0.322
2016 Steel RW, Sack BK, Tsuji M, Kappe SH. An opsonic phagocytosis assay for Plasmodium falciparum sporozoites. Clinical and Vaccine Immunology : Cvi. PMID 27881488 DOI: 10.1128/Cvi.00445-16  0.443
2016 Li X, Huang J, Kaneko I, Zhang M, Iwanaga S, Yuda M, Tsuji M. A potent adjuvant effect of a CD1d-binding NKT cell ligand in human immune system mice. Expert Review of Vaccines. PMID 27801602 DOI: 10.1080/14760584.2017.1256208  0.492
2016 Pereira FV, Melo AC, de Melo FM, Mourão-Sá D, Silva P, Berzaghi R, Herbozo CC, Coelho-Dos-Reis J, Scutti JA, Origassa CS, Pereira RM, Juliano L, Juliano MA, Carmona AK, Câmara NO, ... Tsuji M, et al. TLR4-mediated immunomodulatory properties of the bacterial metalloprotease arazyme in preclinical tumor models. Oncoimmunology. 5: e1178420. PMID 27622031 DOI: 10.1080/2162402X.2016.1178420  0.753
2016 Li X, Huang J, Zhang M, Funakoshi R, Sheetij D, Spaccapelo R, Crisanti A, Nussenzweig V, Nussenzweig RS, Tsuji M. Human CD8+ T cells mediate protective immunity induced by a human malaria vaccine in human immune system mice. Vaccine. PMID 27502569 DOI: 10.1016/J.Vaccine.2016.08.006  0.71
2016 Coelho-Dos-Reis JG, Huang J, Tsao T, Pereira FV, Funakoshi R, Nakajima H, Sugiyama H, Tsuji M. Co-administration of α-GalCer analog and TLR4 agonist induces robust CD8(+) T-cell responses to PyCS protein and WT-1 antigen and activates memory-like effector NKT cells. Clinical Immunology (Orlando, Fla.). PMID 27132023 DOI: 10.1016/J.Clim.2016.04.014  0.553
2016 Zhang M, Kaneko I, Tsao T, Mitchell R, Nardin EH, Iwanaga S, Yuda M, Tsuji M. A highly infectious Plasmodium yoelii parasite, bearing Plasmodium falciparum circumsporozoite protein. Malaria Journal. 15: 201. PMID 27068454 DOI: 10.1186/S12936-016-1248-Z  0.43
2016 Sharma A, Wu W, Sung B, Huang J, Tsao T, Li X, Gomi R, Tsuji M, Worgall S. RSV Pulmonary Infection in Humanized Mice Induces Human Anti-RSV Immune Responses and Pathology. Journal of Virology. PMID 26962219 DOI: 10.1128/Jvi.00259-16  0.462
2015 Huang J, Li X, Coelho-Dos-Reis JG, Zhang M, Mitchell R, Nogueira RT, Tsao T, Noe AR, Ayala R, Sahi V, Gutierrez GM, Nussenzweig V, Wilson JM, Nardin EH, Nussenzweig RS, ... Tsuji M, et al. Human immune system mice immunized with Plasmodium falciparum circumsporozoite protein induce protective human humoral immunity against malaria. Journal of Immunological Methods. PMID 26410104 DOI: 10.1016/J.Jim.2015.09.005  0.68
2015 Li X, Kawamura A, Andrews CD, Miller JL, Wu D, Tsao T, Zhang M, Oren D, Padte NN, Porcelli SA, Wong CH, Kappe SH, Ho DD, Tsuji M. Colocalization of a CD1d-Binding Glycolipid with a Radiation-Attenuated Sporozoite Vaccine in Lymph Node-Resident Dendritic Cells for a Robust Adjuvant Effect. Journal of Immunology (Baltimore, Md. : 1950). 195: 2710-21. PMID 26254338 DOI: 10.4049/Jimmunol.1403017  0.448
2015 Fernández-Arias C, Mashoof S, Huang J, Tsuji M. Circumsporozoite protein as a potential target for antimalarials. Expert Review of Anti-Infective Therapy. 1-4. PMID 26081442 DOI: 10.1586/14787210.2015.1058709  0.401
2015 Birkholz A, Nem?ovi? M, Yu ED, Girardi E, Wang J, Khurana A, Pauwels N, Farber E, Chitale S, Franck RW, Tsuji M, Howell A, Van Calenbergh S, Kronenberg M, Zajonc DM. Lipid and Carbohydrate Modifications of α-Galactosylceramide Differently Influence Mouse and Human Type I Natural Killer T Cell Activation. The Journal of Biological Chemistry. 290: 17206-17. PMID 26018083 DOI: 10.1074/Jbc.M115.654814  0.399
2015 Huang J, Tsao T, Zhang M, Rai U, Tsuji M, Li X. A sufficient role of MHC class I molecules on hepatocytes in anti-plasmodial activity of CD8 (+) T cells in vivo. Frontiers in Microbiology. 6: 69. PMID 25729379 DOI: 10.3389/Fmicb.2015.00069  0.465
2014 Venkataswamy MM, Ng TW, Kharkwal SS, Carreño LJ, Johnson AJ, Kunnath-Velayudhan S, Liu Z, Bittman R, Jervis PJ, Cox LR, Besra GS, Wen X, Yuan W, Tsuji M, Li X, et al. Improving Mycobacterium bovis bacillus Calmette-Guèrin as a vaccine delivery vector for viral antigens by incorporation of glycolipid activators of NKT cells. Plos One. 9: e108383. PMID 25255287 DOI: 10.1371/Journal.Pone.0108383  0.535
2014 Noe AR, Espinosa D, Li X, Coelho-Dos-Reis JG, Funakoshi R, Giardina S, Jin H, Retallack DM, Haverstock R, Allen JR, Vedvick TS, Fox CB, Reed SG, Ayala R, Roberts B, ... ... Tsuji M, et al. A full-length Plasmodium falciparum recombinant circumsporozoite protein expressed by Pseudomonas fluorescens platform as a malaria vaccine candidate. Plos One. 9: e107764. PMID 25247295 DOI: 10.1371/Journal.Pone.0107764  0.454
2014 Huang J, Tsao T, Zhang M, Tsuji M. Circumsporozoite Protein-Specific Kd-Restricted CD8+ T Cells Mediate Protective Antimalaria Immunity in Sporozoite-Immunized MHC-I-Kd Transgenic Mice Mediators of Inflammation. 2014. PMID 25132735 DOI: 10.1155/2014/728939  0.544
2014 Shimizu K, Sato Y, Shinga J, Watanabe T, Endo T, Asakura M, Yamasaki S, Kawahara K, Kinjo Y, Kitamura H, Watarai H, Ishii Y, Tsuji M, Taniguchi M, Ohara O, et al. KLRG+ invariant natural killer T cells are long-lived effectors. Proceedings of the National Academy of Sciences of the United States of America. 111: 12474-9. PMID 25118276 DOI: 10.1073/Pnas.1406240111  0.47
2014 Takaoka A, Iacovidou M, Hasson TH, Montenegro D, Li X, Tsuji M, Kawamura A. Biomarker-guided screening of Juzen-taiho-to, an oriental herbal formulation for immunostimulation. Planta Medica. 80: 283-9. PMID 24549928 DOI: 10.1055/S-0033-1360391  0.337
2014 Huang J, Li X, Coelho-dos-Reis JG, Wilson JM, Tsuji M. An AAV vector-mediated gene delivery approach facilitates reconstitution of functional human CD8+ T cells in mice. Plos One. 9: e88205. PMID 24516613 DOI: 10.1371/Journal.Pone.0088205  0.503
2014 Sack BK, Miller JL, Vaughan AM, Douglass A, Kaushansky A, Mikolajczak S, Coppi A, Gonzalez-Aseguinolaza G, Tsuji M, Zavala F, Sinnis P, Kappe SH. Model for in vivo assessment of humoral protection against malaria sporozoite challenge by passive transfer of monoclonal antibodies and immune serum. Infection and Immunity. 82: 808-17. PMID 24478094 DOI: 10.1128/Iai.01249-13  0.472
2013 Li X, Tsuji M, Schneck J, Webb TJ. Generation of Human iNKT Cell Lines. Bio-Protocol. 3. PMID 27570795  0.33
2013 Li X, Tsuji M, Schneck J, Webb TJ. Generation of Mouse iNKT Cell Lines. Bio-Protocol. 3. PMID 27280122  0.343
2013 Padte NN, Boente-Carrera M, Andrews CD, McManus J, Grasperge BF, Gettie A, Coelho-dos-Reis JG, Li X, Wu D, Bruder JT, Sedegah M, Patterson N, Richie TL, Wong CH, Ho DD, ... ... Tsuji M, et al. A glycolipid adjuvant, 7DW8-5, enhances CD8+ T cell responses induced by an adenovirus-vectored malaria vaccine in non-human primates. Plos One. 8: e78407. PMID 24205224 DOI: 10.1371/Journal.Pone.0078407  0.52
2013 Avci FY, Li X, Tsuji M, Kasper DL. Carbohydrates and T cells: a sweet twosome. Seminars in Immunology. 25: 146-51. PMID 23757291 DOI: 10.1016/J.Smim.2013.05.005  0.473
2013 Kelly H, Mandraju R, Coelho-dos-Reis JGA, Tsuji M. Effects of HIV-1-induced CD1c and CD1d modulation and endogenous lipid presentation on CD1c-restricted T-cell activation Bmc Immunology. 14: 4-4. PMID 23347583 DOI: 10.1186/1471-2172-14-4  0.331
2013 Huang J, Li X, Kohno K, Hatano M, Tokuhisa T, Murray PJ, Brocker T, Tsuji M. Generation of tissue-specific H-2Kd transgenic mice for the study of K(d)-restricted malaria epitope-specific CD8+ T-cell responses in vivo. Journal of Immunological Methods. 387: 254-61. PMID 23142461 DOI: 10.1016/J.Jim.2012.10.019  0.54
2012 Rai U, Huang J, Mishra S, Li X, Shiratsuchi T, Tsuji M. A New Method to Determine Antigen-Specific CD8+ T Cell Activity in Vivo by Hydrodynamic Injection. Biomolecules. 2: 23-33. PMID 24970125 DOI: 10.3390/biom2010023  0.434
2012 Avci FY, Li X, Tsuji M, Kasper DL. Isolation of carbohydrate-specific CD4(+) T cell clones from mice after stimulation by two model glycoconjugate vaccines. Nature Protocols. 7: 2180-92. PMID 23196974 DOI: 10.1038/Nprot.2012.138  0.499
2012 Li X, Polacino P, Garcia-Navarro R, Hu SL, Tsuji M. Peripheral blood invariant natural killer T cells of pig-tailed macaques. Plos One. 7: e48166. PMID 23110202 DOI: 10.1371/Journal.Pone.0048166  0.411
2012 Webb TJ, Li X, Giuntoli RL, Lopez PH, Heuser C, Schnaar RL, Tsuji M, Kurts C, Oelke M, Schneck JP. Molecular identification of GD3 as a suppressor of the innate immune response in ovarian cancer. Cancer Research. 72: 3744-52. PMID 22649190 DOI: 10.1158/0008-5472.Can-11-2695  0.443
2011 Avci FY, Li X, Tsuji M, Kasper DL. A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design. Nature Medicine. 17: 1602-9. PMID 22101769 DOI: 10.1038/Nm.2535  0.461
2011 Kinjo Y, Illarionov P, Vela JL, Pei B, Girardi E, Li X, Li Y, Imamura M, Kaneko Y, Okawara A, Miyazaki Y, Gómez-Velasco A, Rogers P, Dahesh S, Uchiyama S, ... ... Tsuji M, et al. Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria. Nature Immunology. 12: 966-74. PMID 21892173 DOI: 10.1038/Ni.2096  0.456
2011 Mishra S, Rai U, Shiratsuchi T, Li X, Vanloubbeeck Y, Cohen J, Nussenzweig RS, Winzeler EA, Tsuji M, Nussenzweig V. Identification of non-CSP antigens bearing CD8 epitopes in mice immunized with irradiated sporozoites. Vaccine. 29: 7335-42. PMID 21807053 DOI: 10.1016/J.Vaccine.2011.07.081  0.71
2011 Padte NN, Li X, Tsuji M, Vasan S. Clinical development of a novel CD1d-binding NKT cell ligand as a vaccine adjuvant. Clinical Immunology (Orlando, Fla.). 140: 142-51. PMID 21185784 DOI: 10.1016/J.Clim.2010.11.009  0.441
2011 Renukaradhya GJ, Manickam C, Khatri M, Rauf A, Li X, Tsuji M, Rajashekara G, Dwivedi V. Functional invariant NKT cells in pig lungs regulate the airway hyperreactivity: a potential animal model. Journal of Clinical Immunology. 31: 228-39. PMID 21042929 DOI: 10.1007/S10875-010-9476-4  0.373
2010 Shiratsuchi T, Rai U, Krause A, Worgall S, Tsuji M. Replacing adenoviral vector HVR1 with a malaria B cell epitope improves immunogenicity and circumvents preexisting immunity to adenovirus in mice. The Journal of Clinical Investigation. 120: 3688-701. PMID 20811151 DOI: 10.1172/Jci39812  0.38
2010 Li X, Fujio M, Imamura M, Wu D, Vasan S, Wong CH, Ho DD, Tsuji M. Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant. Proceedings of the National Academy of Sciences of the United States of America. 107: 13010-5. PMID 20616071 DOI: 10.1073/Pnas.1006662107  0.432
2010 Lombardi V, Stock P, Singh AK, Kerzerho J, Yang W, Sullivan BA, Li X, Shiratsuchi T, Hnatiuk NE, Howell AR, Yu KO, Porcelli SA, Tsuji M, Kronenberg M, Wilson SB, et al. A CD1d-dependent antagonist inhibits the activation of invariant NKT cells and prevents development of allergen-induced airway hyperreactivity. Journal of Immunology (Baltimore, Md. : 1950). 184: 2107-15. PMID 20083656 DOI: 10.4049/Jimmunol.0901208  0.356
2010 Schmieg J, Yang G, Franck RW, Tsuji M. A multifactorial mechanism in the superior antimalarial activity of alpha-C-GalCer. Journal of Biomedicine & Biotechnology. 2010: 283612. PMID 20069056 DOI: 10.1155/2010/283612  0.308
2010 Vasan S, Tsuji M. A double-edged sword: The role of NKT cells in malaria and HIV infection and immunity Seminars in Immunology. 22: 87-96. PMID 19962909 DOI: 10.1016/J.Smim.2009.11.001  0.369
2010 Sullivan BA, Nagarajan NA, Wingender G, Wang J, Scott I, Tsuji M, Franck RW, Porcelli SA, Zajonc DM, Kronenberg M. Mechanisms for glycolipid antigen-driven cytokine polarization by Valpha14i NKT cells. Journal of Immunology (Baltimore, Md. : 1950). 184: 141-53. PMID 19949076 DOI: 10.4049/Jimmunol.0902880  0.431
2010 Tsuji M. A retrospective evaluation of the role of T cells in the development of malaria vaccine Experimental Parasitology. 126: 421-425. PMID 19944099 DOI: 10.1016/J.Exppara.2009.11.009  0.516
2010 Li X, Shiratsuchi T, Chen G, Dellabona P, Casorati G, Franck RW, Tsuji M. Invariant TCR rather than CD1d shapes the preferential activities of C-glycoside analogues against human versus murine invariant NKT cells (The Journal of Immunology (2009) 183, (4415-4421)) Journal of Immunology. 184. DOI: 10.4049/Jimmunol.0990112  0.338
2009 Horowitz A, Li X, Poles MA, Tsuji M. Use of immobilized HLA-A2:Ig dimeric proteins to determine the level of epitope-specific, HLA-restricted CD8(+) T-cell response. Scandinavian Journal of Immunology. 70: 415-22. PMID 19874545 DOI: 10.1111/J.1365-3083.2009.02317.X  0.475
2009 Li X, Shiratsuchi T, Chen G, Dellabona P, Casorati G, Franck RW, Tsuji M. Invariant TCR rather than CD1d shapes the preferential activities of C-glycoside analogues against human versus murine invariant NKT cells. Journal of Immunology (Baltimore, Md. : 1950). 183: 4415-21. PMID 19734232 DOI: 10.4049/Jimmunol.0901021  0.366
2009 Li X, Chen G, Garcia-Navarro R, Franck RW, Tsuji M. Identification of C-glycoside analogues that display a potent biological activity against murine and human invariant natural killer T cells. Immunology. 127: 216-225. PMID 19489127 DOI: 10.1111/J.1365-2567.2008.02943.X  0.404
2009 Kopecky-Bromberg SA, Fraser KA, Pica N, Carnero E, Moran TM, Franck RW, Tsuji M, Palese P. Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine. Vaccine. 27: 3766-74. PMID 19464560 DOI: 10.1016/J.Vaccine.2009.03.090  0.407
2009 Shiratsuchi T, Schneck J, Kawamura A, Tsuji M. Human CD1 dimeric proteins as indispensable tools for research on CD1-binding lipids and CD1-restricted T cells. Journal of Immunological Methods. 345: 49-59. PMID 19374905 DOI: 10.1016/J.Jim.2009.04.002  0.437
2008 Grajewski RS, Hansen AM, Agarwal RK, Kronenberg M, Sidobre S, Su SB, Silver PB, Tsuji M, Franck RW, Lawton AP, Chan CC, Caspi RR. Activation of invariant NKT cells ameliorates experimental ocular autoimmunity by a mechanism involving innate IFN-gamma production and dampening of the adaptive Th1 and Th17 responses. Journal of Immunology (Baltimore, Md. : 1950). 181: 4791-7. PMID 18802082 DOI: 10.4049/Jimmunol.181.7.4791  0.439
2008 Desruisseaux MS, Gulinello M, Smith DN, Lee SC, Tsuji M, Weiss LM, Spray DC, Tanowitz HB. Cognitive dysfunction in mice infected with Plasmodium berghei strain ANKA. The Journal of Infectious Diseases. 197: 1621-7. PMID 18419550 DOI: 10.1086/587908  0.314
2008 Huang Y, Chen A, Li X, Chen Z, Zhang W, Song Y, Gurner D, Gardiner D, Basu S, Ho DD, Tsuji M. Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, alpha-galactosylceramide. Vaccine. 26: 1807-16. PMID 18329757 DOI: 10.1016/J.Vaccine.2008.02.002  0.406
2007 Vasan S, Poles MA, Horowitz A, Siladji EE, Markowitz M, Tsuji M. Function of NKT cells, potential anti-HIV effector cells, are improved by beginning HAART during acute HIV-1 infection. International Immunology. 19: 943-51. PMID 17702988 DOI: 10.1093/Intimm/Dxm055  0.353
2007 Coppieters K, Van Beneden K, Jacques P, Dewint P, Vervloet A, Vander Cruyssen B, Van Calenbergh S, Chen G, Franck RW, Verbruggen G, Deforce D, Matthys P, Tsuji M, Rottiers P, Elewaut D. A single early activation of invariant NK T cells confers long-term protection against collagen-induced arthritis in a ligand-specific manner. Journal of Immunology (Baltimore, Md. : 1950). 179: 2300-9. PMID 17675491 DOI: 10.4049/Jimmunol.179.4.2300  0.43
2007 Teng MW, Westwood JA, Darcy PK, Sharkey J, Tsuji M, Franck RW, Porcelli SA, Besra GS, Takeda K, Yagita H, Kershaw MH, Smyth MJ. Combined natural killer T-cell based immunotherapy eradicates established tumors in mice. Cancer Research. 67: 7495-504. PMID 17671220 DOI: 10.1158/0008-5472.Can-07-0941  0.428
2006 Kinjo Y, Tupin E, Wu D, Fujio M, Garcia-Navarro R, Benhnia MR, Zajonc DM, Ben-Menachem G, Ainge GD, Painter GF, Khurana A, Hoebe K, Behar SM, Beutler B, Wilson IA, ... Tsuji M, et al. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nature Immunology. 7: 978-86. PMID 16921381 DOI: 10.1038/Ni1380  0.484
2006 Fujii S, Shimizu K, Hemmi H, Fukui M, Bonito AJ, Chen G, Franck RW, Tsuji M, Steinman RM. Glycolipid alpha-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice. Proceedings of the National Academy of Sciences of the United States of America. 103: 11252-7. PMID 16844772 DOI: 10.1073/Pnas.0604812103  0.423
2006 Fujio M, Wu D, Garcia-Navarro R, Ho DD, Tsuji M, Wong CH. Structure-based discovery of glycolipids for CD1d-mediated NKT cell activation: tuning the adjuvant versus immunosuppression activity. Journal of the American Chemical Society. 128: 9022-3. PMID 16834361 DOI: 10.1021/Ja062740Z  0.326
2006 Ophorst OJ, Radosevi? K, Havenga MJ, Pau MG, Holterman L, Berkhout B, Goudsmit J, Tsuji M. Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice. Infection and Immunity. 74: 313-20. PMID 16368986 DOI: 10.1128/Iai.74.1.313-320.2006  0.465
2006 Machado FS, Desruisseaux MS, Nagajyothi, Kennan RP, Hetherington HP, Wittner M, Weiss LM, Lee SC, Scherer PE, Tsuji M, Tanowitz HB. Endothelin in a murine model of cerebral malaria. Experimental Biology and Medicine. 231: 1176-1181. DOI: 10.3181/00379727-232-2311176  0.334
2006 Coppieters K, Beneden KV, Vervloet A, Dewint P, Jacques P, Groeneboer S, Tsuji M, Verbruggen G, Deforce D, Matthys P, Rottiers P, Elewaut D. F.35. Long-Term IFN-γ Dependent Efficacy of Activated Vα14I Natural Killer T-Cells in the Prevention of Collagen-Induced Arthritis Clinical Immunology. 119. DOI: 10.1016/J.Clim.2006.04.075  0.355
2005 Kennan RP, Machado FS, Lee SC, Desruisseaux MS, Wittner M, Tsuji M, Tanowitz HB. Reduced cerebral blood flow and N-acetyl aspartate in a murine model of cerebral malaria. Parasitology Research. 96: 302-307. PMID 15918069 DOI: 10.1007/S00436-005-1349-Z  0.308
2005 Kinjo Y, Wu D, Kim G, Xing GW, Poles MA, Ho DD, Tsuji M, Kawahara K, Wong CH, Kronenberg M. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature. 434: 520-5. PMID 15791257 DOI: 10.1038/Nature03407  0.509
2005 Xing GW, Wu D, Poles MA, Horowitz A, Tsuji M, Ho DD, Wong CH. Synthesis and human NKT cell stimulating properties of 3-O-sulfo-alpha/beta-galactosylceramides. Bioorganic & Medicinal Chemistry. 13: 2907-16. PMID 15781400 DOI: 10.1016/J.Bmc.2005.02.018  0.311
2005 Wu D, Xing GW, Poles MA, Horowitz A, Kinjo Y, Sullivan B, Bodmer-Narkevitch V, Plettenburg O, Kronenberg M, Tsuji M, Ho DD, Wong CH. Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells. Proceedings of the National Academy of Sciences of the United States of America. 102: 1351-6. PMID 15665086 DOI: 10.1073/Pnas.0408696102  0.415
2005 Schmieg J, Yang G, Franck RW, Van Rooijen N, Tsuji M. Glycolipid presentation to natural killer T cells differs in an organ-dependent fashion. Proceedings of the National Academy of Sciences of the United States of America. 102: 1127-32. PMID 15644449 DOI: 10.1073/Pnas.0408288102  0.425
2004 Bruna-Romero O, Rocha CD, Tsuji M, Gazzinelli RT. Enhanced protective immunity against malaria by vaccination with a recombinant adenovirus encoding the circumsporozoite protein of Plasmodium lacking the GPI-anchoring motif. Vaccine. 22: 3575-84. PMID 15315836 DOI: 10.1016/J.Vaccine.2004.03.050  0.479
2003 Schmieg J, Yang G, Franck RW, Tsuji M. Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide. The Journal of Experimental Medicine. 198: 1631-41. PMID 14657217 DOI: 10.1084/Jem.20031192  0.352
2003 Schmieg J, Gonzalez-Aseguinolaza G, Tsuji M. The role of natural killer T cells and other T cell subsets against infection by the pre-erythrocytic stages of malaria parasites. Microbes and Infection. 5: 499-506. PMID 12758279 DOI: 10.1016/S1286-4579(03)00072-8  0.482
2003 Bruna-Romero O, Schmieg J, Val MD, Buschle M, Tsuji M. The Dendritic Cell-Specific Chemokine, Dendritic Cell-Derived CC Chemokine 1, Enhances Protective Cell-Mediated Immunity to Murine Malaria Journal of Immunology. 170: 3195-3203. PMID 12626578 DOI: 10.4049/Jimmunol.170.6.3195  0.578
2003 Tsuji M, Zavala F. T cells as mediators of protective immunity against liver stages of Plasmodium. Trends in Parasitology. 19: 88-93. PMID 12586477 DOI: 10.1016/S1471-4922(02)00053-3  0.578
2002 Tsuji M. Assessing antigen-specific CD8+ and CD4+ T-cell responses in mice after immunization with recombinant viruses. Methods in Molecular Medicine. 72: 361-367. PMID 12125132 DOI: 10.1385/1-59259-271-6:361  0.506
2002 Gonzalez-Aseguinolaza G, Van Kaer L, Bergmann CC, Wilson JM, Schmieg J, Kronenberg M, Nakayama T, Taniguchi M, Koezuka Y, Tsuji M. Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines. The Journal of Experimental Medicine. 195: 617-24. PMID 11877484 DOI: 10.1084/Jem.20011889  0.569
2002 Tsuji M, Zavala F. Peptide-based subunit vaccines against pre-erythrocytic stages of malaria parasites. Molecular Immunology. 38: 433-42. PMID 11741693 DOI: 10.1016/S0161-5890(01)00079-7  0.46
2001 Bruña-Romero O, Hafalla JC, González-Aseguinolaza G, Sano G, Tsuji M, Zavala F. Detection of malaria liver-stages in mice infected through the bite of a single Anopheles mosquito using a highly sensitive real-time PCR. International Journal For Parasitology. 31: 1499-502. PMID 11595237 DOI: 10.1016/S0020-7519(01)00265-X  0.362
2001 Bruña-Romero O, González-Aseguinolaza G, Hafalla JC, Tsuji M, Nussenzweig RS. Complete, long-lasting protection against malaria of mice primed and boosted with two distinct viral vectors expressing the same plasmodial antigen. Proceedings of the National Academy of Sciences of the United States of America. 98: 11491-6. PMID 11553779 DOI: 10.1073/Pnas.191380898  0.712
2001 Tsuji M, Rodrigues EG, Nussenzweig S. Progress toward a malaria vaccine: efficient induction of protective anti-malaria immunity. Biological Chemistry. 382: 553-70. PMID 11405220 DOI: 10.1515/Bc.2001.069  0.7
2000 Fernandez JA, Rodrigues EG, Tsuji M. Multifactorial protective mechanisms to limit viral replication in the lung of mice during primary murine cytomegalovirus infection. Viral Immunology. 13: 287-295. PMID 11016594 DOI: 10.1089/08828240050144626  0.677
2000 Pasquetto V, Guidotti LG, Kakimi K, Tsuji M, Chisari FV. Host-virus interactions during malaria infection in hepatitis B virus transgenic mice Journal of Experimental Medicine. 192: 529-535. PMID 10952722 DOI: 10.1084/Jem.192.4.529  0.394
2000 Cady CT, Lahn M, Vollmer M, Tsuji M, Seo SJ, Reardon CL, O'Brien RL, Born WK. Response of murine gamma delta T cells to the synthetic polypeptide poly-Glu50Tyr50. Journal of Immunology (Baltimore, Md. : 1950). 165: 1790-8. PMID 10925256 DOI: 10.4049/Jimmunol.165.4.1790  0.446
2000 Gonzalez-Aseguinolaza G, de Oliveira C, Tomaska M, Hong S, Bruna-Romero O, Nakayama T, Taniguchi M, Bendelac A, Van Kaer L, Koezuka Y, Tsuji M. alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria. Proceedings of the National Academy of Sciences of the United States of America. 97: 8461-6. PMID 10900007 DOI: 10.1073/Pnas.97.15.8461  0.463
2000 Nagaoka H, Gonzalez-Aseguinolaza G, Tsuji M, Nussenzweig MC. Immunization and Infection Change the Number of Recombination Activating Gene (Rag)-Expressing B Cells in the Periphery by Altering Immature Lymphocyte Production Journal of Experimental Medicine. 191: 2113-2120. PMID 10859336 DOI: 10.1084/Jem.191.12.2113  0.428
2000 Molano A, Park SH, Chiu YH, Nosseir S, Bendelac A, Tsuji M. Cutting edge: the IgG response to the circumsporozoite protein is MHC class II-dependent and CD1d-independent: exploring the role of GPIs in NK T cell activation and antimalarial responses. Journal of Immunology (Baltimore, Md. : 1950). 164: 5005-9. PMID 10799852 DOI: 10.4049/Jimmunol.164.10.5005  0.455
2000 McKenna KC, Tsuji M, Sarzotti M, Sacci JB, Witney AA, Azad AF. gammadelta T cells are a component of early immunity against preerythrocytic malaria parasites. Infection and Immunity. 68: 2224-30. PMID 10722623 DOI: 10.1128/Iai.68.4.2224-2230.2000  0.531
1999 Oliveira CId, Wunderlich G, Levitus G, Soares IS, Rodrigues MM, Tsuji M, Portillo HAd. Antigenic properties of the merozoite surface protein 1 gene of Plasmodium vivax Vaccine. 17: 2959-2968. PMID 10462230 DOI: 10.1016/S0264-410X(99)00176-0  0.446
1999 Yoneto T, Yoshimoto T, Wang CR, Takahama Y, Tsuji M, Waki S, Nariuchi H. Gamma interferon production is critical for protective immunity to infection with blood-stage Plasmodium berghei XAT but neither NO production nor NK cell activation is critical Infection and Immunity. 67: 2349-2356. PMID 10225894 DOI: 10.1128/Iai.67.5.2349-2356.1999  0.436
1999 Fernandez JA, Zavala F, Tsuji M. Phenotypic and functional characterization of CD8(+) T cell clones specific for a mouse cytomegalovirus epitope. Virology. 255: 40-9. PMID 10049820 DOI: 10.1006/Viro.1998.9575  0.502
1999 Rodrigues EG, Zavala F, Nussenzweig RS, Wilson JM, Tsuji M. Efficient induction of protective anti-malaria immunity by recombinant adenovirus. Vaccine. 16: 1812-7. PMID 9795385 DOI: 10.1016/S0264-410X(98)00181-9  0.779
1998 Tsuji M, Bergmann CC, Takita-Sonoda Y, Murata K, Rodrigues EG, Nussenzweig RS, Zavala F. Recombinant Sindbis viruses expressing a cytotoxic T-lymphocyte epitope of a malaria parasite or of influenza virus elicit protection against the corresponding pathogen in mice. Journal of Virology. 72: 6907-10. PMID 9658144 DOI: 10.1128/Jvi.72.8.6907-6910.1998  0.762
1998 Miyahira Y, García-Sastre A, Rodriguez D, Rodriguez JR, Murata K, Tsuji M, Palese P, Esteban M, Zavala F, Nussenzweig RS. Recombinant viruses expressing a human malaria antigen can elicit potentially protective immune CD8+ responses in mice. Proceedings of the National Academy of Sciences of the United States of America. 95: 3954-9. PMID 9520474 DOI: 10.1073/Pnas.95.7.3954  0.72
1998 Tsuji M, Rodrigues EG, Sano G, Nussenzweig RS, Zavala F. Protective immune effector mechanisms against malaria? Parasitology International. 47: 70. DOI: 10.1016/S1383-5769(98)80129-3  0.745
1998 Born W, Cady C, Lahn M, Mukasa A, Tsuji M, Reardon C, O'Brien R. 2.2 Establishment of Murine T-cell Lines and Clones, Hybridomas and Transfectomas Methods in Microbiology. 25: 205-235. DOI: 10.1016/S0580-9517(08)70681-0  0.435
1996 Takita-Sonoda Y, Tsuji M, Kamboj K, Nussenzweig RS, Clavijo P, Zavala F. Plasmodium yoelii: peptide immunization induces protective CD4+ T cells against a previously unrecognized cryptic epitope of the circumsporozoite protein. Experimental Parasitology. 84: 223-30. PMID 8932772 DOI: 10.1006/Expr.1996.0108  0.675
1996 Murata K, García-Sastre A, Tsuji M, Rodrigues M, Rodriguez D, Rodriguez JR, Nussenzweig RS, Palese P, Esteban M, Zavala F. Characterization of in vivo primary and secondary CD8+ T cell responses induced by recombinant influenza and vaccinia viruses. Cellular Immunology. 173: 96-107. PMID 8871605 DOI: 10.1006/Cimm.1996.0255  0.68
1996 Briones MRS, Tsuji M, Nussenzweig V. The large difference in infectivity for mice of Plasmodium berghei and Plasmodium yoelii sporozoites cannot be correlated with their ability to enter into hepatocytes Molecular and Biochemical Parasitology. 77: 7-17. PMID 8784767 DOI: 10.1016/0166-6851(96)02574-1  0.336
1996 Tsuji M, Eyster CL, O'Brien RL, Born WK, Bapna M, Reichel M, Nussenzweig RS, Zavala F. Phenotypic and functional properties of murine gamma delta T cell clones derived from malaria immunized, alpha beta T cell-deficient mice. International Immunology. 8: 359-66. PMID 8728988 DOI: 10.1093/Intimm/8.3.359  0.664
1995 Reardon CL, Heyborne K, Tsuji M, Zavala F, Tigelaar RE, O'Brien RL, Born WK. Murine Epidermal Vγ5/Vδ1-T-Cell Receptor+ T Cells Respond to B-Cell Lines and Lipopolysaccharides Journal of Investigative Dermatology. 105: S58-S61. DOI: 10.1038/Jid.1995.12  0.371
1994 Tsuji M, Mombaerts P, Lefrancois L, Nussenzweig RS, Zavala F, Tonegawa S. Gamma delta T cells contribute to immunity against the liver stages of malaria in alpha beta T-cell-deficient mice. Proceedings of the National Academy of Sciences of the United States of America. 91: 345-9. PMID 8278391 DOI: 10.1073/Pnas.91.1.345  0.689
1994 Tsuji M, Mattei D, Nussenzweig RS, Eichinger D, Zavala F. Demonstration of heat-shock protein 70 in the sporozoite stage of malaria parasites Parasitology Research. 80: 16-21. PMID 8153120 DOI: 10.1007/Bf00932618  0.61
1993 Feng Z, Hoffmann RN, Nussenzweig RS, Tsuji M, Fujioka H, Aikawa M, Lensen TH, Ponnudurai T, Pologe LG. Pfs2400 can mediate antibody-dependent malaria transmission inhibition and may be the Plasmodium falciparum 11.1 gene product. The Journal of Experimental Medicine. 177: 273-81. PMID 8426106 DOI: 10.1084/Jem.177.2.273  0.608
1992 Tsuji M, Corradin G, Zavala F. Monoclonal antibodies recognize a processing dependent epitope present in the mature CS protein of various plasmodial species. Parasite Immunology. 14: 457-69. PMID 1279504 DOI: 10.1111/J.1365-3024.1992.Tb00020.X  0.309
1990 Tsuji M, Romero P, Nussenzweig RS, Zavala F. CD4+ cytolytic T cell clone confers protection against murine malaria. The Journal of Experimental Medicine. 172: 1353-7. PMID 2146361 DOI: 10.1084/Jem.172.5.1353  0.689
1987 Tsuji M, Yagi J, Abe R, Asano Y, Tada T. Shared idiotopes between anti-class II monoclonal antibodies and major histocompatibility complex recognition site of T cells. European Journal of Immunology. 17: 675-681. PMID 2953616 DOI: 10.1002/Eji.1830170515  0.383
Show low-probability matches.